Lifeway Foods, Inc. Stock: price and insider trades · United States
2 insiders bought €7.3M of shares over the last 90 days, the latest by Divisadero Street Capital Management, LP, filed 06 Oct 2026.
Lifeway Foods, Inc.: what insiders have been doing
Lifeway Foods, Inc., founded in 1986, is a Food & Agriculture company based in Morton Grove. Its directors and officers file their transactions with SEC (Form 4). From 6 November 2025 to 6 November 2026, the disclosure feed for Lifeway Foods, Inc. logged 59 filings by 8 insiders.
Both sides are active: 7 purchases worth €7.3M and 27 sales worth €16.4M, from 2 insiders and 2 insiders respectively. Netting one side against the other leaves €9.1M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a purchase of €4.2M from Divisadero Street Capital Management, LP, disclosed on 17 August 2026, or 1.4% of market capitalisation. Among those who bought: 1 major shareholder and 1 chief executive.
In the case of 1 purchase, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The last insider purchase was made public on 6 October 2026, 33 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Across the 3,177 companies tracked on its exchange, the median is 24 filings; at 59 filings, this issuer sits above that mark. Since 2006, the database holds 39 purchases and 677 sales by insiders of the company. The 10-K for the year ended 31 December 2025 shows 212.5 m USD of revenue and 13.9 m USD of net income.
Elsewhere in the same sector, our signals recently picked up insider purchases at Davide Campari - Milano N.V. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -13.9%Entry US$25.91 · Close 04 Nov 2026 US$22.30
- -12.4%Entry US$25.45 · Close 04 Nov 2026 US$22.30
- +63.0%Entry US$6.24 · Close at T+365 US$10.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 66,218 shares@ US$22.58Common Stock, no par valueSEC:0001683168-26-008360:0
- 3,782 shares@ US$23.31Common Stock, no par valueSEC:0001683168-26-008360:1
- 70,000 shares@ US$22.62060.47% mcap4.9% of flowCommon StockSEC144:0001227847-26-000022
- 30,000 shares@ US$22.640.20% mcap2.8% of flowCommon Stock, no par valueSEC:0001683168-26-007902:0
- 30,000 shares@ US$22.6360.20% mcap2.9% of flowCommon StockSEC144:0001227847-26-000021
- 17,482 shares@ US$21.08850.12% mcap4.5% of flowCommon Stock, No Par ValueSEC:0000919574-26-006685:0Canonical exit: 31 Dec 2026 (T+90)
- 36,202 shares@ US$21.00810.24% mcap9.3% of flowCommon Stock, No Par ValueSEC:0000919574-26-006685:1Canonical exit: 3 Jan 2027 (T+90)
- 50,000 shares@ US$20.80380.33% mcap12.8% of flowCommon Stock, No Par ValueSEC:0000919574-26-006685:2Canonical exit: 4 Jan 2027 (T+90)
- 2,000 shares@ US$25.260.014% mcap0.9% of flowCommon Stock, no par valueSEC:0001683168-26-006595:0Canonical exit: 17 Nov 2026 (T+90)
- 35,952 shares@ US$24.78090.25% mcap10.6% of flowCommon Stock, No Par ValueSEC:0000919574-26-005601:2Canonical exit: 15 Nov 2026 (T+90)
- 195,616 shares@ US$24.87291.37% mcap58.3% of flowCommon Stock, No Par ValueSEC:0000919574-26-005601:0Canonical exit: 11 Nov 2026 (T+90)
- 15,000 shares@ US$24.69010.10% mcap4.4% of flowCommon Stock, No Par ValueSEC:0000919574-26-005601:1Canonical exit: 12 Nov 2026 (T+90)
- 75,000 shares@ US$25.44950.54% mcap6.1% of flowCommon StockSEC144:0001227847-26-000020
- 35,000 shares@ US$28.740.28% mcap3.2% of flowCommon Stock, no par valueSEC:0001683168-26-006498:0
- 29,931 shares@ US$24.890.21% mcap2.4% of flowCommon Stock, no par valueSEC:0001683168-26-006498:1
- 45,038 shares@ US$25.820.33% mcap3.7% of flowCommon Stock, no par valueSEC:0001683168-26-006498:2
- 31 shares@ US$26.500.0002% mcap0.0% of flowCommon Stock, no par valueSEC:0001683168-26-006498:3
- 35,000 shares@ US$28.73660.29% mcap3.2% of flowCommon StockSEC144:0001227847-26-000019
- 60,000 shares@ US$30.550.54% mcap8.0% of flowCommon Stock, no par valueSEC:0001683168-26-005734:0
- 40,000 shares@ US$29.460.35% mcap5.2% of flowCommon Stock, no par valueSEC:0001683168-26-005734:1
- 100,000 shares@ US$30.750.91% mcap13.5% of flowCOMMONSEC144:0001000275-26-000094
- 24,653 shares@ US$31.510.23% mcap3.3% of flowCommon Stock, no par valueSEC:0001683168-26-005577:0
- 42,263 shares@ US$32.320.40% mcap5.9% of flowCommon Stock, no par valueSEC:0001683168-26-005577:1
- 6,916 shares@ US$32.02170.065% mcap0.9% of flowCommon StockSEC144:0001227847-26-000017
- 66,916 shares@ US$32.02170.63% mcap9.2% of flowCommon StockSEC144:0001227847-26-000018
25 of 1064 declarations
About Lifeway Foods, Inc.
Lifeway Foods, Inc. (ticker: LWAY) is a U.S.-based company listed on the NASDAQ exchange in the United States, with its corporate headquarters in Morton Grove, Illinois. Founded in 1986 by Michael Smolyansky after his family emigrated from Eastern Europe to the United States, Lifeway has developed into a specialized branded food company focused on cultured dairy and functional nutrition. Its core business is drinkable kefir, the company’s flagship product and the foundation of its brand identity, supported by other fermented dairy offerings positioned in the “better-for-you” category. ([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316825001592/lifeway_i10k-123124.htm?utm_source=openai))
From an operating perspective, Lifeway maintains a largely U.S.-based manufacturing footprint, with facilities in Morton Grove, Illinois; Waukesha, Wisconsin; Niles, Illinois; and Philadelphia, Pennsylvania. The company reports that the vast majority of revenue is derived from products manufactured in its own facilities, which supports tighter control over quality, supply chain execution, and product availability. It also uses third-party co-packers for certain products, which gives it additional flexibility in production capacity. ([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826001886/lifeway_i10k-123125.htm?utm_source=openai))
Read moreShow less
In competitive terms, Lifeway describes itself as the largest producer and marketer of kefir in the United States. That leadership position gives it a differentiated niche in a market that sits at the intersection of probiotics, digestive health, and functional foods. While the competitive landscape includes larger and better-capitalized food companies, Lifeway benefits from strong brand recognition in kefir and from a focused product proposition that is not easily replicated by broadline dairy competitors. ([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826003839/lifeway_i10q-033126.htm?utm_source=openai))
The company’s main product line remains drinkable kefir, but management has been actively broadening the brand into adjacent categories and channels. According to the company’s disclosures, Lifeway is seeking to extend its brand into fresh categories and additional distribution channels such as convenience stores, foodservice, club channels, and drug stores. This suggests a strategy aimed at expanding household penetration while reducing reliance on a narrow set of retail pathways. ([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826001886/lifeway_i10k-123125.htm?utm_source=openai))
Geographically, Lifeway remains primarily a domestic U.S. business, but it has also expanded select international distribution. The company states that its products are now sold across the United States, Mexico, the United Arab Emirates, Central America, and the Caribbean. That international reach is still modest relative to the U.S. market, but it adds optionality for future growth. ([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826003838/lifeway_ex9901.htm?utm_source=openai))
Recent developments are important for investors. In fiscal 2025, Lifeway reported net sales of $212.5 million, up 13.7% year over year, with growth driven mainly by higher volumes of branded drinkable kefir. The company also indicated that comparable sales growth was stronger after adjusting for prior-year customer and logistics changes. In early 2026, it reported continued sales momentum and highlighted ongoing marketing investment. At the same time, fiscal 2025 included elevated legal and professional expenses tied to Danone’s unsolicited purchase proposal and stockholder-related matters, which is a notable governance and overhang issue to monitor. ([sec.gov](https://www.sec.gov/Archives/edgar/data/814586/000168316826001886/lifeway_i10k-123125.htm?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
